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Introduction
Cardiac dysfunction in boys with Duchenne muscular
dystrophy (DMD) is a leading cause of death. Cardiac
resynchronization therapy (CRT) has been shown to
dramatically decrease mortality in eligible adult popula-
tion with congestive heart failure. We hypothesized that
mechanical dyssynchrony is present in DMD patients
and that cardiac magnetic resonance imaging (CMR)
may predict CRT efficacy.
Purpose
We hypothesized that mechanical dyssynchrony is pre-
sent in DMD patients and that cardiac magnetic reso-
nance imaging (CMR) may predict CRT efficacy.
Methods
DMD patients (n=236) were stratified into 4 groups (B-D,
Figure 1) based on age, left ventricular (LV) ejection frac-
tion (EF) and presence of myocardial fibrosis defined as
positive myocardial delayed enhancement (MDE) com-
pared to normal controls (group A, n=77). Dyssynchrony
indices were calculated based on timing of CMR derived
circumferential strain (εcc). The calculated indices
included cross-correlation delay (XCD), uniformity of
strain (US), regional vector of variance (RVV), time to
maximum strain (TTMS) and standard deviation (SD) of
TTMS. Abnormal XCD value was defined as > normal +
2SD. US, RVV, TTMS and SD were than derived for all
patient population and patient with dyssynchrony defined
as abnormal XCD.
Results
There was overall low prevalence of circumferential dys-
synchrony in the entire DMD population (3%); it
increased to 17.1% for patients with abnormal EF and to
31.2% in the most advanced stage (abnormal EF with
fibrosis) (Table 1 and 2). All but one DMD patient with
mechanical dyssynchrony exhibited normal QRS dura-
tion suggesting absence of electrical dyssynchrony. The
calculated US and RVV values (0.91 ± 0.09, 1.34 ± 0.48)
indicate disperse rather than clustered dyssynchrony.
Conclusion
Mechanical dyssynchrony is frequent in boys with end
stage DMD-associated cardiac dysfunction. It is asso-
ciated with normal QRS complex as well as extensive
1CCHMC, Cincinnati, OH, USA
Full list of author information is available at the end of the article
Figure 1
Hor et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):O17
http://jcmr-online.com/content/13/S1/O17
© 2011 Hor et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
lateral fibrosis. Based on these findings, it is unlikely
that this patient population will benefit from CRT.
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Table 1 General Characteristic by Group
Group
Parameter A (n=77) B (n=90) C (n=111) D (n=19) E (n=16)
Age (years) (min,
max)
13.9 ± 8.9 (4.8, 46.6) 8.5 ± 0.9** (6.6, 10.0) 12.9 ± 2.8 (10.0, 24.8) 15.0 ± 3.9 (10.3, 24.0) 17.3 ± 5.4** (8.7, 26.4)
LVEF (%) (min, max) 64.6 ± 5.9 (48.9, 76.2) 65.0 ± 4.8 (55.2, 82.7) 64.4 ± 5.8 (55.3, 83.3) 49.4 ± 6.6** (31.6, 54.4) 36.5 ± 12.2** (17.3, 54.0)
XCDa(ms) 45.6 ± 16.9 (0, 83.3) 35.3 ± 16.6 (0, 70.5) 38.2 ± 19.8 (0, 112.5) 52.2 ± 22.4 (27.5, 105) 73.0 ± 41.9 (21.3, 157.5)
US_max (min, max) 0.97 ± 0.04 (0.84, 1.00) 0.98 ± 0.03 (0.90, 1.00) 0.97 ± 0.03 (0.86, 1.00) 0.97 ± 0.04 (0.88, 1.00) 0.92 ± 0.08** (0.73, 1.00)
TTMS (min, max) 78.2 ± 31.8 (0.0, 148.8) 65.4 ± 22.9** (21.3,
157.5)
71.2 ± 24.0 (21.3,
105.8)
95.1 ± 19.6** (56.5,
140.0)
111.4 ± 33.0** (63.8,
157.5)
RVV_max (min, max) 0.95 ± 0.57 (0.10, 2.8) 1.03 ± 0.55 (0.04, 2.7) 1.13 ± 0.57 (0.14, 2.7) 1.03 ± 0.51 (0.35, 2.16) 1.34 ± 0.57** (0.42, 2.2)
STD_peak (min, max) 31.7 ± 12.0 (0, 56.1) 26.7 ± 8.4** (11.6, 55.1) 29.6 ± 9.7 (8.7, 52.7) 36.5 ± 6.9 (21.3, 47.8) 46.1 ± 16.6** (24.8, 75.7)
QRS (min, max) 92.8 ± 11.41 85.1 ± 7.8** (70, 104) 86.6 ± 8.0** (68, 109) 86.1 ± 13.4 (68, 126) 97.1 ± 21.9 (80, 134)
εcc (min, max) -18.2 ± 4.5 (-17.4,
-25.5)
-14.2 ± 1.4** (-10.4,
-16.3)
-13.2 ± 2.0** (-6.5,
-16.5)
-10.7 ± 2.1 (-7.4, -14.2) -7.0 ± 2.8 (-2.8, -11.9)
εcc = Circumferential strain, Group A = Control subjects, Group B = DMD age ≤10 yrs, Group C = DMD age > 10 yrs with normal EF and MDE negative, Group D
= DMD age > 10 yrs with reduced EF and MDE negative, Group E = DMD age > 10 years with reduced EF and positive MDE, LVEF = Left ventricular ejection
fraction, MDE = myocardial delayed enhancement, STD = Standard deviation, TTMS = Time to maximum strain, US = Uniformity of strain, RVV = Regional vector
of variance, XCD = Cross correlation delay, XCDa = maximum of (XCD 1-4, XCD 2-5 and XCD 3.6).
Table 2 Abnormal XCDs vs. the control
Group
Parmaeter Control (n=77) Abnormal XCDs (n=9)
Age (min, max) 13.9 ± 8.9 (4.8, 46.6) 16.7 ± 5.0 (10.9, 24.3)
LVEF (%) (min, max) 64.6 ± 5.9 (48.9, 76.2) 43.9 ± 16.7** (17.3, 61.9)
XCDa (min, max) 45.6 ± 16.9 (0, 83.3) 116.5 ± 20.5** (93.8, 157.5)
Presence of MDE 0 (0.0%) 4 (57.1%)**
US_max (min, max) 0.97 ± 0.04 (0.84, 1.00) 0.91 ± 0.09** (0.73, 0.98)
TTMS (min, max) 78.2 ± 31.8 (0.0, 148.8) 111.2 ± 39.5** (37.5, 157.5)
RVV_max (min, max) 0.95 ± 0.57 (0.10, 2.8) 1.34 ± 0.48 (0.42, 2.0)
STD_peak (min, max) 31.7 ± 12.0 (0, 56.1) 47.6 ± 18.1**
QRS (min, max) 92.8 ± 11.41 (74, 122) 98.2 ± 15.3 (86, 134)
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